Successful ABO-incompatible living donor liver transplantation using splenectomy and intravenous immunoglobulin in high isoagglutinin titer patients

The role of the isoagglutinin (IA) titer in liver transplantation (LT) is still not well defined, but the general belief is that a higher titer may result in a higher risk of rejection in ABO-incompatible living donor LT. To reduce the IA titer by 1:16 or lower, plasmapheresis is usually performed b...

Full description

Bibliographic Details
Main Authors: Boram Lee, Jai Young Cho, Hae Won Lee, YoungRok Choi, Yoo-Seok Yoon, Ho-Seong Han
Format: Article
Language:English
Published: Korean Society for Transplantation 2020-06-01
Series:Korean Journal of Transplantation
Subjects:
Online Access:http://journaleditor.inforang.com/journal/view.html?doi=10.4285/kjt.2020.34.2.109
_version_ 1827365353190064128
author Boram Lee
Jai Young Cho
Hae Won Lee
YoungRok Choi
Yoo-Seok Yoon
Ho-Seong Han
author_facet Boram Lee
Jai Young Cho
Hae Won Lee
YoungRok Choi
Yoo-Seok Yoon
Ho-Seong Han
author_sort Boram Lee
collection DOAJ
description The role of the isoagglutinin (IA) titer in liver transplantation (LT) is still not well defined, but the general belief is that a higher titer may result in a higher risk of rejection in ABO-incompatible living donor LT. To reduce the IA titer by 1:16 or lower, plasmapheresis is usually performed before transplantation. However, there is no established protocol for patients for whom plasmapheresis has failed before reaching the target IA titers. Here, we report the cases of three patients who show high baseline IA titers and have failed plasmapheresis: no-response to plasmapheresis, allergic reaction associated with plasmapheresis, and anaphylactic reaction to platelet transfusion. For various reasons, after several plasmapheresis procedures, IA titers were not effectively reduced. In these patients, splenectomy and intravenous immunoglobulin (0.8 g/kg, from the anhepatic phase to 2 days after transplantation) were carried. The protocol biopsy on postoperative day 7 showed no histologic evidence of meaningful acute rejection. The main aim of this work is to demonstrate that we can apply this protocol to patients who have high baseline IA titers and have failed plasmapheresis. Furthermore, this report is enhanced to promote to the transplant community this approach with this type of recipient.
first_indexed 2024-03-08T08:27:06Z
format Article
id doaj.art-13904a81cf78485ca01a53df4023298e
institution Directory Open Access Journal
issn 2671-8790
language English
last_indexed 2024-03-08T08:27:06Z
publishDate 2020-06-01
publisher Korean Society for Transplantation
record_format Article
series Korean Journal of Transplantation
spelling doaj.art-13904a81cf78485ca01a53df4023298e2024-02-02T04:20:13ZengKorean Society for TransplantationKorean Journal of Transplantation2671-87902020-06-0134210911310.4285/kjt.2020.34.2.109kjt.2020.34.2.109Successful ABO-incompatible living donor liver transplantation using splenectomy and intravenous immunoglobulin in high isoagglutinin titer patientsBoram Lee0Jai Young Cho1Hae Won Lee2YoungRok Choi3Yoo-Seok Yoon4Ho-Seong Han5Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, KoreaDepartment of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, KoreaDepartment of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, KoreaDepartment of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, KoreaDepartment of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, KoreaDepartment of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, KoreaThe role of the isoagglutinin (IA) titer in liver transplantation (LT) is still not well defined, but the general belief is that a higher titer may result in a higher risk of rejection in ABO-incompatible living donor LT. To reduce the IA titer by 1:16 or lower, plasmapheresis is usually performed before transplantation. However, there is no established protocol for patients for whom plasmapheresis has failed before reaching the target IA titers. Here, we report the cases of three patients who show high baseline IA titers and have failed plasmapheresis: no-response to plasmapheresis, allergic reaction associated with plasmapheresis, and anaphylactic reaction to platelet transfusion. For various reasons, after several plasmapheresis procedures, IA titers were not effectively reduced. In these patients, splenectomy and intravenous immunoglobulin (0.8 g/kg, from the anhepatic phase to 2 days after transplantation) were carried. The protocol biopsy on postoperative day 7 showed no histologic evidence of meaningful acute rejection. The main aim of this work is to demonstrate that we can apply this protocol to patients who have high baseline IA titers and have failed plasmapheresis. Furthermore, this report is enhanced to promote to the transplant community this approach with this type of recipient.http://journaleditor.inforang.com/journal/view.html?doi=10.4285/kjt.2020.34.2.109liver transplantation; plasmapheresis; graft rejection; splenectomy; immunoglobulinsintravenous
spellingShingle Boram Lee
Jai Young Cho
Hae Won Lee
YoungRok Choi
Yoo-Seok Yoon
Ho-Seong Han
Successful ABO-incompatible living donor liver transplantation using splenectomy and intravenous immunoglobulin in high isoagglutinin titer patients
Korean Journal of Transplantation
liver transplantation; plasmapheresis; graft rejection; splenectomy; immunoglobulins
intravenous
title Successful ABO-incompatible living donor liver transplantation using splenectomy and intravenous immunoglobulin in high isoagglutinin titer patients
title_full Successful ABO-incompatible living donor liver transplantation using splenectomy and intravenous immunoglobulin in high isoagglutinin titer patients
title_fullStr Successful ABO-incompatible living donor liver transplantation using splenectomy and intravenous immunoglobulin in high isoagglutinin titer patients
title_full_unstemmed Successful ABO-incompatible living donor liver transplantation using splenectomy and intravenous immunoglobulin in high isoagglutinin titer patients
title_short Successful ABO-incompatible living donor liver transplantation using splenectomy and intravenous immunoglobulin in high isoagglutinin titer patients
title_sort successful abo incompatible living donor liver transplantation using splenectomy and intravenous immunoglobulin in high isoagglutinin titer patients
topic liver transplantation; plasmapheresis; graft rejection; splenectomy; immunoglobulins
intravenous
url http://journaleditor.inforang.com/journal/view.html?doi=10.4285/kjt.2020.34.2.109
work_keys_str_mv AT boramlee successfulaboincompatiblelivingdonorlivertransplantationusingsplenectomyandintravenousimmunoglobulininhighisoagglutinintiterpatients
AT jaiyoungcho successfulaboincompatiblelivingdonorlivertransplantationusingsplenectomyandintravenousimmunoglobulininhighisoagglutinintiterpatients
AT haewonlee successfulaboincompatiblelivingdonorlivertransplantationusingsplenectomyandintravenousimmunoglobulininhighisoagglutinintiterpatients
AT youngrokchoi successfulaboincompatiblelivingdonorlivertransplantationusingsplenectomyandintravenousimmunoglobulininhighisoagglutinintiterpatients
AT yooseokyoon successfulaboincompatiblelivingdonorlivertransplantationusingsplenectomyandintravenousimmunoglobulininhighisoagglutinintiterpatients
AT hoseonghan successfulaboincompatiblelivingdonorlivertransplantationusingsplenectomyandintravenousimmunoglobulininhighisoagglutinintiterpatients